Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 25, 2019 | Gracell Biotechnologies | $85.0M Series B | Temasek | Chengdu Miaoji, Kington Capital, Lilly Asia Ventures |
| May 9, 2018 | CStone Pharmaceuticals | $259.2M Series B | GIC | 3W Partners, 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), Taikang, Terra Magnum Capital Partners, WuXi Healthcare Ventures, Yunfeng Capital |
| Mar 1, 2018 | Adagene | $50.0M Series C | Hongshan Capital Group (Sequoia Capital China) | Base Partners, DST Global, Carmen Chang, Hans Tung, Paradigm, Sequoia Capital China, AVIC Trust, Gopher Asset Management, New World TMT |